DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Capital Market: DBVT) (the "Company”), a late-stage biopharmaceutical company, today reported financial results for the full year 2025.

December 31, 2025 and $104.2 million tangible book value(1) as of December 31, 2025; $129.3 million improvement in net loss and $66.0 mil ...

As the use of electric vehicles (EVs) has grown, there has been some confusion as to how VAT should be applied to supplies at public charging ...

Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian ...

Kingsoft Cloud Holdings Limited (NASDAQ:KC) Q4 2025 Earnings Call Transcript March 25, 2026 Kingsoft Cloud Holdings Limited ...

Increased ARR Leads to Higher Gross Margins and Adjusted EBITDAQ4 2025 revenue grew modestly to $5.8M compared to $5.7M ...

The case examined whether a 2345-day delay could be condoned based on reasons like miscommunication and financial hardship. The Tribunal held that vague explanations and negligence do not qualify as ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. David ...

Ever wonder how the bracket is filled out? Or why one team makes it and another doesn't? IndyStar's Zach Osterman got a sneak ...

Increasing tax revenue is a key plank of the IMF program. Since May 2022 the Government has introduced new taxes, adjusted ...

As the Braves are owned by a publicly traded company, the franchise is an anomaly in MLB: its books are open, even after ...